CAM
AGN

Capstone Asset Management’s Allergan Inc AGN Stock Holding History

Capstone Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-23,795
Closed -$5.06M – 1694
2014
Q4 		$5.06M Buy
23,795
+2,687
+13% +$534K 0.15% 174
2014
Q3 		$3.76M Buy
21,108
+310
+1% +$51.5K 0.13% 191
2014
Q2 		$3.52M Sell
20,798
-26,792
-56% -$4.17M 0.11% 218
2014
Q1 		$5.91M Sell
47,590
-2,817
-6% -$343K 0.18% 132
2013
Q4 		$5.6M Sell
50,407
-13,780
-21% -$1.32M 0.16% 144
2013
Q3 		$5.81M Sell
64,187
-526
-0.8% -$47.2K 0.14% 155
2013
Q2 		$5.45M Buy
+64,713
New +$6.71M 0.14% 151

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Capstone Asset Management's AGN Position: Q1 2015 in Review

Capstone Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 23,795 shares — an estimated $5.06M sold.

Capstone Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $5.91M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Capstone Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Capstone Asset Management sold 23,795 Allergan Inc shares in Q1 2015, an estimated $5.06M.
  • Capstone Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Capstone Asset Management's Allergan Inc position peaked at $5.91M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Capstone Asset Management's 13F filing for Q1 2015, filed 10 Apr 2015.